Anticonvulsant

The FDA warned that women taking topiramate in the first trimester more often had babies with cleft lip and palate: 1.4% of infants exposed on single-drug therapy, against 0.38% to 0.55% on other anticonvulsants and 0.07% with no exposure. Stronger labeling will be required.